Search
for
Sort by
Research 30 of 267
- Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Insights into the peripheral nature of persistent sexual dysfunction associated with post-finasteride, post-SSRI and post-accutane syndromes: lessons learned from a case study
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)
- Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI)
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Trichotillomania
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases
- Adverse Cutaneous Reactions to Antidepressants
- Psychological interventions in the management of common skin conditions
- Psychocutaneous disease
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Dermatologic Side Effects of Psychotropic Medications
- Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods
- Antidepressants have Anti-inflammatory Effects that may be Relevant to Dermatology: A Systematic Review
- Psychodermatology
- Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines
- CSF 5-HIAA as a predictor of treatment response in trichotillomania.
- Under-diagnosed psychiatric syndrome. I: Trichotillomania.
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Obsessive-compulsive disorder in dermatology
- The gut‐microbiota‐brain axis: Focus on gut steroids
- Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
- Bupropion for the treatment of fluoxetine non-responsive trichotillomania: a case report
- Trichotillomania: What Do We Know So Far?